ATP6V0A4 and Hearing impairment: However, with more recent clinical follow up data, we have become aware that hearing impairment may represent a spectrum in dRTA, and hearing loss may also develop at an older age in a number of those affected patients with ATP6V0A4 mutations, but likely less severe than in those with ATP6V1B1 mutations [9].